Latest Insights — M&A, Digital Transformation & Compliance

Three converging regulatory developments — the EU Digital Omnibus, full EU AI Act enforcement from August 2026, and a US Supreme Court ruling threatening the EU–US Data Privacy Framework — are reshaping enterprise risk management across Europe. Corporate leaders must act now to address dual AI-GDPR compliance obligations and stress-test transatlantic data transfer mechanisms.

Deloitte’s 2026 State of AI Report confirms enterprise AI has crossed from experimentation into scaled production, with organisations deploying eleven times more models than the prior year. Yet only 20% have mature governance for autonomous AI agents — a gap that represents both regulatory exposure and strategic risk for European executives.

Three landmark deals totalling over $33 billion — Merck KGaA’s acquisition of Bio-Techne, ON Semi’s purchase of Synaptics, and Uber’s bid for Delivery Hero — signal a decisive acceleration in cross-border M&A activity across life sciences, AI hardware, and logistics. Decision-makers must navigate elevated regulatory scrutiny and integration complexity to capture strategic value.

A single week of M&A announcements exceeding $90 billion — led by Merck KGaA, Uber, and ON Semiconductor — reveals where strategic capital is concentrating in 2025. Decision-makers must act on the regulatory, valuation, and integration implications now.

The Iran conflict has triggered the most significant energy crisis since the 1970s, forcing a fundamental reassessment of geopolitical risk for business across supply chains, M&A, and capital allocation. European executives must act now — the window for reactive adjustment is closing.

Instagram’s native Competitive Insights feature and Google’s mandatory AI content disclosure are reshaping how European businesses approach brand monitoring and digital reputation management. With the social media analytics market projected to reach $107.3 billion by 2035, social intelligence is now a board-level strategic discipline.

Merck KGaA’s $11.3B acquisition of Bio-Techne and ON Semiconductor’s $7B Synaptics deal mark a defining moment in cross-border M&A, reflecting structural consolidation in life sciences and AI hardware. Decision-makers must act now to build the regulatory, financial, and integration capabilities required to compete in this environment.

A wave of cross-border M&A transactions totaling over $25 billion — led by Merck KGaA’s $11.3B acquisition of Bio-Techne — signals a strategic realignment across life sciences, energy, and AI sectors in 2025. Decision-makers must act with speed while navigating an increasingly complex regulatory and integration landscape.

A surge of landmark transactions — from ON Semiconductor’s $7B AI-driven acquisition to Merck KGaA’s $11.3B life sciences deal — is reshaping global M&A strategy in 2025. Decision-makers must prioritize regulatory pre-clearance, rigorous due diligence, and post-merger integration to capitalize on this deal cycle.

Geopolitical risk references in Fortune 250 filings have quadrupled since 2009, as the Iran conflict, US reciprocal tariffs, and US-China tech decoupling converge into a structural challenge for global business strategy. European CFOs, General Counsel, and boards must now integrate geopolitical scenario planning as a core governance discipline.